Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in VCEL — Vericel Corp

CIK 1179392 NEW YORK, NY
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,847,889
+$10,245,053 QoQ
Shares Held
580,982
+19.8% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 317 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. VCEL ranks #48 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in VCEL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,847,889 580,982
2026-03-31 $15,602,836 485,012
2025-12-31 $1,422,322 39,498
2025-09-30 $1,658,878 52,713
2023-12-31 $825,831 23,191
2023-09-30 $781,887 23,326
2023-06-30 $2,954,392 78,637
2023-03-31 $1,143,362 38,996
2022-12-31 $3,344,047 126,957
2022-09-30 $3,438,866 148,227
2022-06-30 $4,726,739 187,718
2022-03-31 $1,282,968 33,568
2021-12-31 $3,629,865 92,363
2021-09-30 $5,505,225 112,812
2021-06-30 $2,382,082 45,373
2020-12-31 $605,248 19,600
2020-09-30 $627,648 33,872
2020-06-30 $2,740,685 198,313
2020-03-31 $704,549 76,832